Division of Pulmonary, Critical Care & Sleep Medicine, University of California San Diego, La Jolla, California.
Division of Pulmonary, Critical Care & Sleep Medicine, University of California San Diego, La Jolla, California.
Ann Thorac Surg. 2023 Jul;116(1):121-128. doi: 10.1016/j.athoracsur.2022.11.003. Epub 2022 Nov 8.
Airway hemorrhage is a known complication of pulmonary thromboendarterectomy (PTE) in patients with chronic thromboembolic pulmonary hypertension. Predisposing factors for postoperative airway hemorrhage have not been well described. The aims of this study were to determine the incidence and outcomes of airway hemorrhage after PTE and to identify potential risk factors.
This was a retrospective chart review of subjects undergoing PTE between 2015 and 2019. Postoperative airway hemorrhage was defined as significant endobronchial bleeding requiring withholding anticoagulation, bronchial blocker placement, and/or extracorporeal membrane oxygenation (ECMO).
Of 877 subjects who underwent PTE, 58 subjects (6.6%) developed postoperative airway hemorrhage. Subjects with hemorrhage were more likely to be women (60% vs 45%, P = .03), to be older (57.8 vs 54.0 years, P = .04), and to have a higher incidence of preoperative hemoptysis (19.0% vs 7.6%, P = .006) compared with control subjects (subjects without airway hemorrhage). Those with hemorrhage had significantly higher preoperative right atrial pressure (P = .002) and pulmonary vascular resistance (P < .001) and a higher incidence of residual pulmonary hypertension (P = .005). Airway hemorrhage management included ECMO with bronchial blocker (n = 2), bronchial blocker without ECMO (n = 26), or withholding anticoagulation alone until bleeding subsided (n = 30). Mortality was significantly higher in those with airway hemorrhage compared with control subjects (13.8% vs 1.2%, P < .001).
The incidence of postoperative airway hemorrhage is low but associated with significant mortality. Older age, female sex, preoperative hemoptysis, and worse preoperative pulmonary hypertension were associated with an increased risk of developing postoperative airway hemorrhage.
气道出血是慢性血栓栓塞性肺动脉高压患者行肺动脉血栓内膜剥脱术(PTE)后的已知并发症。术后气道出血的易患因素尚未得到很好的描述。本研究旨在确定 PTE 后气道出血的发生率和结果,并确定潜在的危险因素。
这是一项回顾性图表研究,纳入了 2015 年至 2019 年间接受 PTE 的患者。术后气道出血定义为需要停止抗凝、放置支气管阻塞器和/或体外膜肺氧合(ECMO)的显著支气管内出血。
在 877 名接受 PTE 的患者中,有 58 名(6.6%)发生术后气道出血。与对照组(无气道出血的患者)相比,出血组患者更有可能是女性(60% vs 45%,P =.03)、年龄更大(57.8 岁 vs 54.0 岁,P =.04)、术前咯血发生率更高(19.0% vs 7.6%,P =.006)。与对照组相比,出血组患者术前右心房压(P =.002)和肺血管阻力(P <.001)显著升高,且残余肺动脉高压发生率更高(P =.005)。气道出血的管理包括 ECMO 联合支气管阻塞器(n = 2)、仅支气管阻塞器(n = 26)或单独停止抗凝直至出血停止(n = 30)。与对照组相比,气道出血患者的死亡率显著更高(13.8% vs 1.2%,P <.001)。
术后气道出血的发生率较低,但与显著的死亡率相关。年龄较大、女性、术前咯血和更严重的术前肺动脉高压与术后气道出血风险增加相关。